Sargent Investment Group’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $470K | Hold |
50,000
| – | – | 0.06% | 159 |
|
|
2025
Q1 | $345K | Hold |
50,000
| – | – | 0.06% | 177 |
|
|
2024
Q4 | $263K | Buy |
+50,000
| New | +$263K | 0.04% | 199 |
|
|
2022
Q3 | – | Sell |
-16,000
| Closed | -$27K | – | 195 |
|
|
2022
Q2 | $27K | Hold |
16,000
| – | – | 0.01% | 182 |
|
|
2022
Q1 | $39K | Hold |
16,000
| – | – | 0.01% | 183 |
|
|
2021
Q4 | $60K | Sell |
16,000
-5,000
| -24% | -$18.8K | 0.01% | 181 |
|
|
2021
Q3 | $132K | Buy |
21,000
+1,000
| +5% | +$6.29K | 0.03% | 181 |
|
|
2021
Q2 | $197K | Hold |
20,000
| – | – | 0.05% | 185 |
|
|
2021
Q1 | $187K | Hold |
20,000
| – | – | 0.05% | 180 |
|
|
2020
Q4 | $96K | Sell |
20,000
-5,000
| -20% | -$24K | 0.03% | 170 |
|
|
2020
Q3 | $100K | Buy |
25,000
+13,000
| +108% | +$52K | 0.04% | 157 |
|
|
2020
Q2 | $54K | Sell |
12,000
-82,000
| -87% | -$369K | 0.02% | 146 |
|
|
2020
Q1 | $306K | Buy |
94,000
+82,000
| +683% | +$267K | 0.14% | 110 |
|
|
2019
Q4 | $52K | Buy |
+12,000
| New | +$52K | 0.02% | 152 |
|
|
2019
Q3 | – | Sell |
-102,000
| Closed | -$474K | – | 153 |
|
|
2019
Q2 | $474K | Sell |
102,000
-1,500
| -1% | -$6.97K | 0.22% | 88 |
|
|
2019
Q1 | $434K | Hold |
103,500
| – | – | 0.21% | 87 |
|
|
2018
Q4 | $355K | Buy |
+103,500
| New | +$355K | 0.22% | 87 |
|